XT
SGMT icon

XTX Topco’s Sagimet Biosciences SGMT Stock Holding History

XTX Topco’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$199K Sell
38,099
-53,638
-58% -$299K ﹤0.01% 2846
2025
Q4 		$543K Buy
91,737
+32,003
+54% +$230K 0.01% 1517
2025
Q3 		$410K Buy
59,734
+34,110
+133% +$277K 0.02% 1235
2025
Q2 		$195K Buy
25,624
+14,813
+137% +$62.5K 0.01% 1713
2025
Q1 		$35.2K Buy
+10,811
New +$45.3K ﹤0.01% 2048
2024
Q3 		– Sell
-41,548
Closed -$142K – 2552
2024
Q2 		$142K Sell
41,548
-17,615
-30% -$80.8K 0.01% 1340
2024
Q1 		$321K Buy
59,163
+44,682
+309% +$321K 0.04% 797
2023
Q4 		$78.5K Buy
+14,481
New +$68.3K 0.02% 1156

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

XTX Topco's SGMT Position: Q1 2026 in Review

XTX Topco reduced its Sagimet Biosciences (SGMT) stake by 58% in Q1 2026, selling an estimated $299K and leaving 38,099 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

XTX Topco first reported a position in SGMT in Q4 2023 and has held it in 8 quarters since. The position peaked at $543K in Q4 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • XTX Topco held 38,099 shares of Sagimet Biosciences worth $199K as of Q1 2026.
  • XTX Topco sold 53,638 Sagimet Biosciences shares in Q1 2026, an estimated $299K.
  • Sagimet Biosciences made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2846 holding.
  • XTX Topco first reported a position in Sagimet Biosciences in Q4 2023 and has held it in 8 quarters since.
  • XTX Topco's Sagimet Biosciences position peaked at $543K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.